Jennifer Sharpe Potter
Affiliation: University of Texas Health Science Center
- Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials NetworkJennifer Sharpe Potter
Division of Alcohol and Drug Abuse, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
J Subst Abuse Treat 38:S80-6. 2010..These findings lend further support for continued research on pain among patients with opioid dependence...
- Site selection in community-based clinical trials for substance use disorders: strategies for effective site selectionJennifer Sharpe Potter
Division of Alcohol and Drug Abuse, Department of Psychiatry, School of Medicine, University of Texas Health Science Center, San Antonio, 78232, USA
Am J Drug Alcohol Abuse 37:400-7. 2011..Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders...
- Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trialRoger D Weiss
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
Arch Gen Psychiatry 68:1238-46. 2011..No randomized trials have examined treatments for prescription opioid dependence, despite its increasing prevalence...
- Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trialGeorge E Woody
Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
JAMA 300:2003-11. 2008..The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful...
- Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)Madhukar H Trivedi
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 9119, USA
Am J Drug Alcohol Abuse 37:339-49. 2011..Abstinence is the most desirable treatment outcome although a wide variety of other endpoints have been used...
- Characteristics of first-time alcohol treatment seekers: the COMBINE StudyJoseph S Locastro
Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, and Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA
J Stud Alcohol Drugs 69:885-95. 2008....